The Influence of Hydro-Alcoholic Media on Drug Release - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

The Influence of Hydro-Alcoholic Media on Drug Release
The authors investigate the influence of hydro-alcoholic media on hydration and drug release from polyethylene oxide extended-release matrices.

Pharmaceutical Technology
Volume 35, Issue 7, pp. 50-58

26. H.M. Fadda, M.A.M Mohamed, and A.W. Basit, Int. J. Pharm. 360 (1-2) 171–176 (2008).

27. M. Walden et al., Drug. Dev. Ind. Pharm. 33 (10) 1101–1111 (2007).

28. J. Koziara, J. So, and N. Agarwal, presentation at the AAPS Annual Meeting and Exposition (San Antonio, TX, 2006).

29. M. Roberts et al., Int. J. Pharm. 332 (1-2) 31–37 (2007).

30. M.J. Traynor et al., Drug. Dev. Ind. Pharm. 34 (8) 885–889 (2008).

31. S. Missaghi, K.A. Fegely, and A.R. Rajabi-Siahboomi, AAPS. PharmSci. 10 (1) 77–80 (2009).

32. B. Ager et al., presentation at the 36th Annual Meeting & Exposition of the Controlled Release Society (Copenhagen, Denmark, 2009).

33. J.E.F. Reynolds, K. Parfitt, A.V. Parsons, S.C. Sweetman, Eds., Martindale, The Extra Pharmacopoeia, 29th ed. (Pharmaceutical Press, London, UK, 1989).

34. A.C. Moffat, M.D. Osselton, and B. Widdop, Eds., Clarke's Analysis of Drugs and Poisons, Vol. 2 (Pharmaceutical Press, London, 2004).

35. N. Seedher, and M. Kanojia, Pharm. Dev. Technol. 14 (2) 185–192 (2009).

36. F.E. Bailey Jr. and J.V. Koleski, Poly(ethy1ene oxide), Chapter 5 (Academic Press, New York, 1976) p. 87.

37. Colorcon "HyperStart services," (2010).

38. FDA, "The Influence of Hydrophilic Pore Formers on Dipyridamole Release from Aqueous Ethylcellulose Film-Coated Pellets," Fed. Regist., 60 (230) p.61642 (1995).

39. P.L. Ritger, and N.A. Peppas, J. Control. Release. 5 (1) 23–36 (1987).

40. P.L. Ritger and N.A. Peppas, J. Control. Release. 5 (1) 37–42 (1987).

41. R. Espinoza, E. Hong, and L. Villafuerte, Int. J. Pharm. 201 (2) 165–173 (2000).

42. J.L. Ford et al., Int. J. Pharm. 71 (1-2) 95–104 (1991).

43. N.K. Ebube et al., Int. J. Pharm. 156 (1) 49–57 (1997).

44. N.K. Ebube et al., Pharm. Dev. Technol. 2 (2) 161–170 (1997).

45. K. Tahara, K. Yamamoto, and T. Nishihata, J. Control. Release. 35 (1) 59–66 (1995).

46. N. Kavanagh and O.I. Corrigan, Int. J. Pharm. 279 (1-2) 141–152 (2004).

47. S.P. Panomsuk et al., Chem. Pharm. Bull. 44 (5) 1039–1042 (1996).

48. J.C. Bode and C. Bode, Alcohol Malnutrition and the Gastrointestinal Tract, in: Nutrition and Alcohol, R.R. Watson, B. Watzl, Eds. (CRC Press, Boca Raton, FL, 1992) pp. 403–428.

49. C. Bode, J.C. Bode, Alcohol. Health. Res. W. 21 (1) 76–83 (1997).

50. A.F. Brown, D.S. Jones, and A.D. Woolfson, supplement to J. Pharm. Pharmacol. 50 157 (1998).

51. D.S. Jones et al., presentation at the AAPS Annual Meeting and Exposition (Toronto, ON, Canada, 2002).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here